Distributive Shock and Anaphylaxis

Aug 23, 2025

Overview

This lecture covers distributive shock, focusing on sepsis and anaphylaxis, including their pathophysiology, recognition criteria, clinical features, prevention, and management strategies.

Distributive Shock Overview

  • Distributive shock (vasodilatory shock) includes sepsis and anaphylaxis, both characterized by inappropriate vasodilation and maldistribution of blood volume.
  • Leads to decreased cardiac output and tissue perfusion.

Sepsis: Pathophysiology & Recognition

  • Sepsis starts with a precipitating infection causing local inflammation and can progress to SIRS (systemic inflammatory response syndrome).
  • SIRS criteria: two or more of the following—fever (>38°C) or hypothermia (<36°C), tachycardia, tachypnea (RR >20 or PaCO2 <32), abnormal WBC count (<4,000 or >12,000, or >10% bands).
  • Sepsis = SIRS + confirmed or suspected infection; severe sepsis = sepsis + organ dysfunction; septic shock = sepsis with refractory hypotension; MODS = failure of two or more organs.

Sepsis: Management & Prevention

  • Prevention: scrub IV lines with alcohol, sterile dressing changes, timely removal of invasive devices, and early detection.
  • Obtain two sets of blood cultures before antibiotics; draw from different sites 15 minutes apart.
  • Remove or culture any indwelling lines before inserting new ones.
  • Elevated lactic acid (>2 mmol/L = elevated, >4 mmol/L = poor prognosis); reassess after fluid bolus.
  • Initiate with two large bore IVs, give 30 mL/kg fluid bolus; use vasopressors if hypotension persists.
  • Fluid challenge: raise legs to assess BP response—if BP rises, fluid responsive; otherwise, consider vasopressors.
  • Complete initial sepsis assessment ideally within 1 hour.

Anaphylaxis: Pathophysiology & Recognition

  • Anaphylaxis is a severe allergic reaction, commonly triggered by foods, medications, insect stings, latex, or environmental factors.
  • Mediated by IgE antibodies, which activate mast cells to release histamine (causes vasodilation, bronchospasm) and other mediators.
  • Symptoms vary but may include hives, airway swelling, wheezing, and in severe cases, cardiovascular collapse.
  • First exposure may cause little reaction; subsequent exposures may be more severe.
  • Allergies can be hereditary; prevention includes avoiding triggers and carrying an EpiPen.

Anaphylaxis: Management

  • Severity determines management; time of onset and amount/type of exposure affect severity.
  • Mild: nasal congestion, hives, tingling, warmth within 2 hours.
  • Moderate: above symptoms plus flushing, anxiety, coughing, airway swelling, and wheezing.
  • Severe: rapid onset, includes airway closure, cyanosis, hypotension, diarrhea, vomiting, cardiac arrest.
  • Monitor patients for recurrent reactions (may occur within 48 hours).
  • Epinephrine: adults 0.3 mg IM (1:1,000), children 0.01 mg/kg IM; IV epinephrine only during cardiac arrest (1:10,000).
  • Additional meds: corticosteroids (solu-medrol), antihistamines (diphenhydramine for H1, famotidine/pepsid for H2).
  • Never give 1:1,000 concentration IV.

Key Terms & Definitions

  • Distributive Shock — shock due to vasodilation and maldistribution of blood flow.
  • SIRS (Systemic Inflammatory Response Syndrome) — clinical response to widespread inflammation with set criteria.
  • MODS (Multi-Organ Dysfunction Syndrome) — dysfunction of at least two organ systems from severe illness or injury.
  • Sepsis — life-threatening organ dysfunction due to a dysregulated body response to infection.
  • Anaphylaxis — rapid, severe allergic reaction involving multiple body systems.
  • IgE — antibody responsible for triggering allergic responses.
  • Epinephrine — medication used as first-line treatment in anaphylaxis.

Action Items / Next Steps

  • Practice recognizing SIRS criteria and early sepsis signs.
  • Review proper technique for obtaining and culturing blood/line specimens.
  • Learn and rehearse EpiPen use and allergy assessment protocols.
  • Prepare for neurogenic shock in the next lecture.